MicrofluidX
MicrofluidX is tackling the problems of process control, scalability, and cost associated with cell bioprocessing, in particular for autologous cell and gene therapy. Its automated, closed technology allows biologists to easily carry out process development by running dozens of cell culture conditions in parallel with extreme process control, and to scale up seamlessly up to several billion cells for manufacturing at a fraction of the current costs.
See other Cell and Gene organisations
-
Achilles Therapeutics is a biopharmaceutical company developing personalised T cell therapies targeting clonal neoantigens: protein markers unique to the individual ... -
Aglaris Ltd produce equipment to ensure cell and tissue culture is an easy, problem-free task. -
Autolus is founded on advanced cell programming technology pioneered by Dr Martin Pule and was spun-out from University College London ... -
The Cell and Gene Therapy Catapult was established in 2012 as an independent centre of excellence to advance…
Find out more about becoming one of our occupiers and all of the benefits of being at SBC. Contact us today.
Get in touchCopyright © 2023 Stevenage Bioscience Catalyst
We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.